María-Teresa Gómez-Casares

13PUBLICATIONS
88CO-AUTHORS
Haematological tumoursMolecular targetsHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|Jun 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|Sep 22, 2025
Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia.

Carol Herrera-Hernández, Adrián Segura-Diaz, Ruth Stuckey

|May 07, 2025
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis.

David M Ross, Florian H Heidel, Andrew Charles Perkins

|Apr 07, 2025
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs.

Ruth Stuckey, Laura Navarrete Bullón, Asunción Borrero Borrego

Pageof 3

Frequent Collaborators

8 joint publications

Ruth Stuckey

5 joint publications

Beatriz Cuevas

5 joint publications

Francisca Ferrer-Marín

5 joint publications

Juan-Carlos Hernández-Boluda